Willis-Knighton seeks participants for clinical trials of COVID-19 treatments

Willis-Knighton Health System is expanding its clinical trials of monoclonal antibodies for outpatient treatment of people infected with COVID-19. Willis-Knighton is one of 120 sites nationwide and th…